9,077
Total Claims
$1.6M
Drug Cost
1,051
Beneficiaries
$1,497
Cost/Patient
Peer Comparison vs. 4,479 Interventional Cardiology providers
+42%
Cost per patient vs peers
$1,497 vs $1,054 avg
+19%
Brand preference vs peers
15.6% vs 13.1% avg
Brand vs Generic
84% generic
Brand: 1,416 claims · $1.4M
Generic: 7,661 claims · $154K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 638 | $720K |
| Sacubitril/Valsartan | 186 | $206K |
| Rivaroxaban | 138 | $186K |
| Evolocumab | 114 | $131K |
| Alirocumab | 67 | $57K |
| Empagliflozin | 34 | $37K |
| Icosapent Ethyl | 34 | $19K |
| Pitavastatin Calcium | 25 | $16K |
| Ezetimibe | 337 | $10K |
| Metoprolol Succinate | 613 | $9,711 |
| Atorvastatin Calcium | 772 | $8,231 |
| Omega-3 Acid Ethyl Esters | 66 | $7,964 |
| Rosuvastatin Calcium | 467 | $7,388 |
| Icosapent Ethyl | 19 | $6,614 |
| Clonidine | 38 | $6,583 |
Prescribing Profile
58
Unique Drugs
$1.1M
Patient Profile
76
Avg Age
48%
Female
1.53
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About